LPS administration is known to elevate cytokine levels such as IL-1β, IL-6, and TNF-α, which contribute to neuroinflammation and are implicated in mood disorders (Naha et al., 2010; Zhao et al., 2019). This evidence concerns the gene IL1B and mood disorder.